|Bid||31.68 x 1000|
|Ask||35.70 x 1000|
|Day's range||31.49 - 32.57|
|52-week range||28.65 - 48.50|
|Beta (5Y monthly)||1.07|
|PE ratio (TTM)||N/A|
|Earnings date||24 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||50.83|
LEWISVILLE, Texas, January 19, 2022--Orthofix and nView medical announce partnership to develop and co-market systems for cervical spine and pediatric limb deformity procedures.
LEWISVILLE, Texas, January 10, 2022--Orthofix Medical Inc. (NASDAQ:OFIX) today announced preliminary unaudited fourth quarter 2021 net sales of approximately $125 million, an increase of 6% on a reported basis and 7% on a constant currency basis versus fourth quarter 2020. On a sequential basis, compared to the third quarter of 2021, net sales increased 11%. For the full year 2021, preliminary unaudited net sales were approximately $464 million, an increase of 14% on a reported basis and 13% on
LEWISVILLE, Texas, December 14, 2021--Orthofix names Thomas A. West to the Company's Board of Directors and appoints him to the Compensation and Talent Development Committee.